Skip to content
Shuttingdown

Esperion Therapeutics, Inc.

Pharmaceutical Preparations · ANN ARBOR

No longer listed

High confidence (85%)

Updated Oct 17, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

Latest material event: Esperion Therapeutics, Inc. deregistered its securities (Jul 23, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Esperion Therapeutics, Inc. deregistered its securities

    Jul 23, 2026

    Registration withdrawn

    • SEC EDGAR — “15-12G 1 tm2620034d30_1512g.htm FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-35986 Esperion Therapeutics, Inc. (Exact name of registrant as specified in its charter) 3891 Ranchero Drive, Suite 150 Ann Arbor, Michigan 48108 (734) 887-3903 (Address, including zip code, and telephone number, including area…”

  2. Esperion Therapeutics, Inc. received a delisting notice from its exchange

    Jul 13, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continuing Listing Rule or Standard; Transfer of Listing. In connection with the consummation of the Merger, on July 13, 2026, the Company (i) notified The Nasdaq Stock Market LLC ( Nasdaq ) of the consummation of the Merger and (ii) requested that Nasdaq file with the Securities and Exchange Commission (the SEC ) a Notification of Removal from Listing and/or Registration on Form 25 to delist and deregister the shares of Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act ). As a result, the…”

  3. Esperion Therapeutics, Inc. was delisted from its exchange

    Jul 13, 2026

    Delisting effective

    • SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001434868 Esperion Therapeutics, Inc. 001-35986 3891 Ranchero Drive, Suite 150 Ann Arbor MI MICHIGAN 48108 (734) 887-3903 Common Stock 17 CFR 240.12d2-2(a)(3) Tara Petta AVP 2026-07-13”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
SEC CIK
0001434868
Website
—
LinkedIn
—
Headquarters
ANN ARBOR
Also known as
HDL THERAPEUTICS INC
Legal entities
Esperion Therapeutics, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Esperion Therapeutics, Inc. — Pharmaceutical Preparations (SIC 2834) — ANN ARBOR, MI
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    15-12G 1 tm2620034d30_1512g.htm FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-35986 Esperion Therapeutics, Inc. (Exact name of registrant as specified in its charter) 3891 Ranchero Drive, Suite 150 Ann Arbor, Michigan 48108 (734) 887-3903 (Address, including zip code, and telephone number, including area…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    X0203 0001354457 Nasdaq Stock Market LLC 0001434868 Esperion Therapeutics, Inc. 001-35986 3891 Ranchero Drive, Suite 150 Ann Arbor MI MICHIGAN 48108 (734) 887-3903 Common Stock 17 CFR 240.12d2-2(a)(3) Tara Petta AVP 2026-07-13
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continuing Listing Rule or Standard; Transfer of Listing. In connection with the consummation of the Merger, on July 13, 2026, the Company (i) notified The Nasdaq Stock Market LLC ( Nasdaq ) of the consummation of the Merger and (ii) requested that Nasdaq file with the Securities and Exchange Commission (the SEC ) a Notification of Removal from Listing and/or Registration on Form 25 to delist and deregister the shares of Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act ). As a result, the…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:32 AM

    The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:15 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:03 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:21 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:21 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.